← 홈

ADC · 림프종

161개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 161개
ADCBiologicstaleCelgeneVedotinPhase 1

Romidepsin (Romidepsin)

Breast Adenocarcinoma; Metastatic Breast Carcinoma · Cutaneous T-cell Lymphoma (CTCL)

#CutaneousT-cellLymphomaCTCL#ADC#Phase1#인기#항체약물접합체+5
효능 ORR 50%임상시험 53상태 ACTIVE
ADCBiologicstaleKing Abdullah International Med…Vedotin Plus AVD versus ABV…Phase 2

ABVD (ABVD)

Classical Hodgkin Lymphoma; Hodgkin Lymphoma (Category) · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 96%임상시험 52상태 ACTIVE
ADCBiologicstaleSWOG Cancer Research NetworkVedotin, and BelinostatPhase 3

Pirtobrutinib (Pirtobrutinib)

Richter Syndrome; Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 66.4%임상시험 52상태 RECRUITING
ADCBiologicstaleRochevedotin, rituximab, cycloph…Phase 2

Polatuzumab (Polatuzumab)

Diffuse Large B Cell Lymphoma (DLBCL); High Grade B Cell Lymphoma · Lymphoma

#Lymphoma#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 100%임상시험 52상태 RECRUITING
ADCBiologicSWOG Cancer Research NetworkVedotin Plus AVD versus ABV…Phase 2

Velban (Vinblastine, Vinblastine (Velban))

Anaplastic Large Cell Lymphoma, ALK-Positive · Anaplastic Large Cell Lymphoma, ALK-Posi

#AnaplasticLargeCellLymphomaALK-P#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 96%임상시험 52상태 RECRUITING
ADCBiologicstaleSeagenvedotin-containing regimen …Phase 2

SGN-35 (brentuximab vedotin, brentuximab vedotin (SGN-35))

Hodgkin's Lymphoma · Hodgkin's Lymphoma

#HodgkinsLymphoma#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 89.5%임상시험 52상태 ACTIVE
ADCBiologicstaleSeagenvedotin-containing regimen …Phase 2

Adcetris (Brentuximab vedotin, Brentuximab vedotin (Adcetris))

Anaplastic Large Cell Lymphoma, ALK-Positive · Anaplastic Large Cell Lymphoma, ALK-Posi

#AnaplasticLargeCellLymphomaALK-P#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 89.5%임상시험 51상태 RECRUITING
ADCBiologicSeagen Inc.Vedotin Plus AVD versus ABV…Phase 2

Adriamycin, vinblastine, and dacarbazine (Adriamycin, vinblastine, and dacarbazine)

Hodgkin Lymphoma · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 96%임상시험 50상태 ACTIVE
ADCBiologicstaleMedImmune LLCvedotin combined with cispl…Phase 2

DHAP (DHAP)

Diffuse Large B-Cell Lymphoma · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
효능 ORR 47.5%임상시험 48상태 ACTIVE
ADCBBiologicstaleADC TherapeuticsthatPhase 2

Anti-CD19 Antibody-Drug Conjugate (Loncastuximab Tesirine, Loncastuximab Tesirine (Anti-CD19 Antibody-Drug Conjugate))

Diffuse Large B-Cell Lymphoma; High-grade B-cell Lymphoma (HGBCL) · CD19

#CD19#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
효능 ORR 94.1%임상시험 48상태 RECRUITING
ADCBiologicPharmacyclics LLC.vedotin plus doxorubicin [A…Phase 3

Procarbazine Hydrochloride (Procarbazine Hydrochloride)

Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 · Lugano Classification Limited Stage Hodg

#LuganoClassificationLimitedStage#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 1%임상시험 45상태 RECRUITING
ADCBiologicEisai Inc.Phase 2

DOC Group B (DOC Group B)

Non-hodgkin Lymphoma; Hodgkin Lymphoma · Non-hodgkin Lymphoma

#Non-hodgkinLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 42상태 RECRUITING
ADCBiologicstaleMillennium Pharmaceuticals, Inc.Vedotin or Other Standard T…Phase 3

Bexarotene (Bexarotene)

Primary Cutaneous Anaplastic Large Cell Lymphoma; Mycosis Fungoides · Primary Cutaneous Anaplastic Large Cell

#PrimaryCutaneousAnaplasticLargeC#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+4
효능 ORR 54.7%임상시험 40상태 ACTIVE
ADCBiologicTakedaDM1 in HER2-Positive Breast…Phase 1

TAK228 (TAK228)

Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic; Classical Hodgkin Lymphoma · CD30

#CD30#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+5
효능 ORR 18.4%임상시험 40상태 DISCONTINUED
ADCBiologicstaleCelgenePhase 2

CC-220 (CC-220)

Lymphoma · Lymphoma, B-Cell

#LymphomaB-Cell#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 71.4%임상시험 37상태 DISCONTINUED
ADCBiologicstaleIncyte CorporationPhase 1

Parsaclisib (Parsaclisib)

Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage II Follicular Lymphoma · Ann Arbor Stage II Diffuse Large B-Cell

#AnnArborStageIIDiffuseLargeB-Cel#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 88.1%임상시험 34상태 RECRUITING
ADCBiologicstaleVerastem, Inc.Phase 2

Defactinib (Defactinib)

Advanced Lymphoma; Advanced Malignant Solid Neoplasm · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 3.2%임상시험 30상태 RECRUITING
ADCBiologicstaleChinese Academy of Medical Scie…Preclinical

Maintenance therapy-chidamide (Maintenance therapy-chidamide)

CD30+ Peripheral T-cell Lymphoma · CD30

#CD30#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+2
임상시험 30상태 RECRUITING
ADCBiologicstaleFondazione Italiana Linfomi - E…Phase 2

R-DHAP (R-DHAP)

Diffuse Large B Cell Lymphoma Refractory; Diffuse Large B-cell Lymphoma Recurrent · DLBCL

#DLBCL#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 51.4%임상시험 30상태 DISCONTINUED
ADCBiologicstaleCalithera Biosciences, IncPhase 2

Sapanisertib (Sapanisertib)

Advanced Lymphoma; Advanced Malignant Solid Neoplasm · FRα

#FR#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 18.4%임상시험 30상태 RECRUITING

3 / 9 페이지

← 이전다음 →